BRIEF SUMMARY of MasterPeace Clinical Pilot Study Results
This study evaluated 3 adults (2 women, 1 man, ages 57-60) over a 90 day
period who consumed MasterPeace.
It measured their systemic toxic load of major harmful toxins before and after, with an average
reduction of toxic burden by 41.7% across all participants and toxins. To determine this, the
study used the iEC – intracellular electrical capacity – in lymphocytes test, as defined by IGL
Laboratory, to assess levels of systemic toxic burden.
There were particularly notable individual reductions in various toxins such as:
87.1% reduction in Graphene Oxide (Subject 2)
93.6% reduction in PFOA (Perfluorooctanoic acid) (Subject 3)
84.7% reduction in Aluminum (Subject 2)
88.8% reduction in Polypropylene(PP) (Subject 2)
This unprecedented study demonstrates that MasterPeace is safe, effective, and fast-performing —
helping participants to reduce their cellular toxicity from some of today’s most harmful chemicals
in just 30-90 days.
NOTE:
Following the sudden passing of its founder in 2024, IGL Laboratory experienced operational disruption and
subsequently discontinued the iEC (intracellular electrical capacity in lymphocytes) test. Prior to this,
iEC testing had been offered for over a decade, with details publicly available on the IGL website,
including the following:
MasterPeace Pilot Study/Human Cellular Toxin Clinical Study - A Peer Reviewed &
Published Medical Paper
